heparin disaccharide

structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Inclusion Body Myositis 10/01/2023 - "In contrast, based on Class I evidence, IVIG is not recommended for inclusion body myositis, post-polio syndrome, IgM paraproteinemic neuropathy and small fiber neuropathy that is idiopathic or associated with tri-sulfated heparin disaccharide or fibroblast growth factor receptor-3 autoantibodies. "
2.	Postpoliomyelitis Syndrome (Post-Polio Syndrome) 10/01/2023 - "In contrast, based on Class I evidence, IVIG is not recommended for inclusion body myositis, post-polio syndrome, IgM paraproteinemic neuropathy and small fiber neuropathy that is idiopathic or associated with tri-sulfated heparin disaccharide or fibroblast growth factor receptor-3 autoantibodies. "
3.	Respiratory Hypersensitivity 06/01/2014 - "To test this, we produced a supersulfated heparin disaccharide (Hep-SSD) and evaluated its anti-allergic activity in sheep with documented antigen-induced early and late airway responses (EAR and LAR) and airway hyperresponsiveness (AHR). "
4.	Neoplasm Metastasis (Metastasis) 04/01/2019 - "Design and synthesis of a native heparin disaccharide grafted poly‑2‑aminoethyl methacrylate glycopolymer for inhibition of melanoma cell metastasis."
5.	Melanoma (Melanoma, Malignant) 04/01/2019 - "Design and synthesis of a native heparin disaccharide grafted poly‑2‑aminoethyl methacrylate glycopolymer for inhibition of melanoma cell metastasis."

1.	Anti-Allergic Agents (Antiallergic Agents)
2.	Intravenous Immunoglobulins (IVIG)
3.	Silver Sulfadiazine (SSD)
4.	Methacrylates
5.	Immunoglobulin M (IgM)
6.	Fibroblast Growth Factors (Fibroblast Growth Factor)
7.	Disaccharides
8.	Chondroitin
9.	Autoantibodies
10.	Antigens